Skip to content
AASLD Family of Websites: Liver Fellow Network
AASLD.org AASLD Foundation LiverLearning Career Center Journals The Liver Meeting HCV Guidelines
AASLD Logo
AASLD Logo

LFN Main Navigation

  • Topics
  • Core Series
    Back to Basics Clinical Pearls Webinars Evidence Corner Pathology Pearls Liver Talks Podcasts The Why? Series Tools of the Trade View All Core Series
  • Tweetorials
  • About
  • Acute Liver Failure
  • Alcohol-Associated Liver Disease
  • Autoimmune Hepatitis
  • Career Development and Mentorship
  • Cholestatic Liver Disease
  • Complications of Liver Disease and Portal Hypertension
  • Drug-Induced Liver Disease
  • Guidelines
  • HepMadness
  • Inherited Disorders
  • Liver Anatomy, Development, and Physiology
  • Liver Infections
  • Liver Physiology
  • Liver Related Infections
  • MASLD/MASH
  • Neoplasms of the Liver
  • Pathology
  • Pediatrics
  • Practice Questions
  • Pregnancy-Related Liver Disease
  • Symptoms and Clinical Presentation of Liver Disease and Portal HTN
  • Systemic Conditions with Hepatic Manifestations
  • Transplantation and Surgery
  • Vascular
  • Video Tutorials
  • Viral Hepatitis
  • Guidelines
  • Drug, Herbal And Dietary Supplement-Induced Liver Injury

Drug, Herbal and Dietary Supplement-Induced Liver Injury

January 12, 2026

Beverly Kyalwazi

Share

Copy Link Twitter Facebook

Link to the full guidelines: https://journals.lww.com/hep/fulltext/2023/03000/aasld_practice_guidanc…

Drug-Induced Liver Disease

Share

Copy Link Twitter Facebook

Written By:

Beverly Kyalwazi

GI Fellow, UTSW

Related Content

Chronic Hepatitis B: 2025 Updates

January 15, 2026

LFN Guidelines: Alcohol-associated Liver Disease

September 25, 2025

AASLD LFN Logo

Follow Us

Disclaimer & Privacy Policy

© 2026 copyright